Rintaro Noro Selected Research

Adjuvant Chemotherapy

9/2022	Benefits from Adjuvant Chemotherapy in Patients with Resected Non-Small Cell Lung Cancer: Possibility of Stratification by Gene Amplification of ACTN4 According to Evaluation of Metastatic Ability.
3/2022	Alpha-actinin-4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas.
1/2017	Actinin-4 protein overexpression as a predictive biomarker in adjuvant chemotherapy for resected lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rintaro Noro Research Topics

Disease

33	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 07/2006
29	Neoplasms (Cancer) 04/2024 - 06/2006
28	Lung Neoplasms (Lung Cancer) 04/2024 - 06/2006
13	Adenocarcinoma of Lung 01/2023 - 02/2014
8	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2024 - 05/2013
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2023 - 10/2012
5	Adenocarcinoma 01/2023 - 12/2006
5	Neoplasm Metastasis (Metastasis) 01/2023 - 02/2014
3	Malignant Mesothelioma 02/2019 - 06/2014
2	Brain Neoplasms (Brain Tumor) 03/2024 - 01/2023
2	Carcinoma (Carcinomatosis) 04/2022 - 11/2018
2	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 05/2013
2	Organizing Pneumonia 01/2022 - 02/2021
2	Carcinogenesis 01/2021 - 09/2012
2	Pleural Effusion (Pleural Effusions) 01/2021 - 02/2013
2	Malignant Pleural Effusion 01/2020 - 02/2013
2	Idiopathic Interstitial Pneumonias 12/2019 - 01/2009
2	Pneumonia (Pneumonitis) 02/2019 - 05/2013
2	Renal Cell Carcinoma (Grawitz Tumor) 04/2015 - 05/2013
2	Breast Neoplasms (Breast Cancer) 04/2015 - 06/2010
1	Adenoid Cystic Carcinoma (Cylindroma) 09/2023
1	Anemia 01/2023
1	Hemolytic Anemia 01/2023
1	Ulcerative Colitis 01/2023
1	Crohn Disease (Crohn's Disease) 01/2023
1	Meningitis 01/2023
1	Margins of Excision 09/2022
1	Superior Mesenteric Artery Syndrome 04/2022
1	Dizziness (Lightheadedness) 04/2022
1	Weight Loss (Weight Reduction) 04/2022
1	Vomiting 04/2022
1	Thymoma (Thymic Carcinoma) 04/2022
1	Aspergillus niger infection 01/2022
1	Pulmonary Aspergillosis 01/2022
1	Chemical and Drug Induced Liver Injury 01/2022
1	Hepatitis 01/2022
1	Inflammation (Inflammations) 01/2022

Drug/Important Bio-Agent (IBA)

11	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 06/2006
9	osimertinibIBA 04/2024 - 01/2018
9	Biomarkers (Surrogate Marker)IBA 03/2023 - 12/2006
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2006
9	ErbB Receptors (EGF Receptor)IBA 01/2023 - 11/2007
8	Tyrosine Kinase InhibitorsIBA 01/2023 - 11/2007
7	Bevacizumab (Avastin)FDA Link 01/2023 - 02/2013
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 06/2006
6	Anaplastic Lymphoma KinaseIBA 01/2023 - 05/2013
6	pembrolizumabIBA 04/2022 - 01/2018
6	Gefitinib (Iressa)FDA Link 02/2015 - 12/2006
5	MicroRNAs (MicroRNA)IBA 03/2023 - 09/2012
5	AfatinibIBA 01/2023 - 10/2018
4	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2019 - 06/2002
4	Cisplatin (Platino)FDA LinkGeneric 03/2013 - 06/2006
4	Histone Deacetylase InhibitorsIBA 06/2010 - 11/2007
3	amrubicinIBA 07/2023 - 03/2013
3	LigandsIBA 03/2023 - 12/2006
3	Albumin-Bound Paclitaxel FDA Link 04/2022 - 02/2019
3	Docetaxel (Taxotere)FDA Link 08/2015 - 06/2006
3	Messenger RNA (mRNA)IBA 07/2015 - 11/2007
3	Gemcitabine FDA Link 01/2011 - 06/2006
2	TOR Serine-Threonine KinasesIBA 01/2024 - 04/2015
2	Everolimus FDA Link 01/2024 - 05/2013
2	Immune Checkpoint InhibitorsIBA 03/2023 - 01/2020
2	130-nm albumin-bound paclitaxelIBA 01/2023 - 01/2022
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2023 - 05/2013
2	alectinibIBA 01/2023 - 01/2023
2	Pemetrexed (MTA)FDA Link 02/2022 - 06/2014
2	SteroidsIBA 01/2022 - 11/2018
2	CrizotinibIBA 01/2017 - 04/2015
2	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2014 - 09/2012
2	Irinotecan (Camptosar)FDA LinkGeneric 03/2013 - 10/2012
2	Cadherins (E-Cadherin)IBA 09/2012 - 02/2008
2	Fluorouracil (Carac)FDA LinkGeneric 06/2010 - 06/2007
2	theasinensin AIBA 07/2008 - 11/2007
2	Vinorelbine (Navelbine)FDA LinkGeneric 06/2007 - 06/2006
2	Complementary DNA (cDNA)IBA 06/2007 - 06/2006
1	Antineoplastic Agents (Antineoplastics)IBA 01/2024
1	durvalumabIBA 09/2023
1	atezolizumabIBA 01/2023
1	cremophorIBA 01/2023
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2023
1	Azathioprine (Imuran)FDA LinkGeneric 01/2023
1	BilirubinIBA 01/2023
1	Mesalamine (Mesalazine)FDA LinkGeneric 01/2023
1	EnzymesIBA 01/2023
1	Formaldehyde (Formol)FDA Link 03/2022
1	TegafurIBA 03/2022
1	ParaffinIBA 03/2022
1	UracilIBA 03/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Topoisomerase InhibitorsIBA 01/2022

Therapy/Procedure

21	Therapeutics 09/2023 - 06/2006
14	Drug Therapy (Chemotherapy) 04/2022 - 06/2007
3	Adjuvant Chemotherapy 09/2022 - 01/2017
2	Pleurodesis 01/2020 - 02/2013
2	Aftercare (After-Treatment) 06/2018 - 04/2015
1	Molecular Targeted Therapy 04/2024
1	Chemoradiotherapy 09/2023
1	Telescopes 01/2023
1	Drug Tapering 01/2023
1	Blood Transfusion (Blood Transfusions) 01/2023